REFILE-Trial finds GSK Ebola shot is safe and provokes immune response
January 29, 2015 at 02:08 AM EST
LONDON, Jan 28 (Reuters) - First results from a human trial of an Ebola vaccine from GlaxoSmithKline show it is safe and generates an immune response, scientists said on Wednesday, but larger trials are needed to see if it protects and if a booster is needed.
